Literature DB >> 23704429

Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer.

Arunjit Singh Takhar1, Alex Ney, Meera Patel, Anup Sharma.   

Abstract

We report the case of a 53-year-old lady who presented with a lump in her left breast. Her initial investigations demonstrated a grade III invasive ductal carcinoma of the breast that was tethered to the pectoralis major; imaging and cytology also revealed metastatic nodes in the left axilla. After undergoing neoadjuvant chemotherapy with evidence of clinical and radiological tumour response, a wire-guided wide local excision and axillary node clearance was performed. When a histological analysis of the specimen was performed, there was no evidence of a viable metastatic tumour in the axillary lymph nodes, but there were several areas of extramedullary haematopoiesis. There are only two other reports in the literature of this finding. This could represent a potential source of false-positive diagnosis of axillary metastasis from breast cancer. It would be prudent to consider biopsy prior to clearance if there are megakaryocytes in axillary node cytology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23704429      PMCID: PMC3669812          DOI: 10.1136/bcr-2013-008943

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Pseudomicrometastasis in sentinel lymph node-multinucleated macrophage mimicking micrometastasis.

Authors:  A Chiu; R S Hoda; S A Hoda
Journal:  Breast J       Date:  2001 Nov-Dec       Impact factor: 2.431

2.  Megakaryocytes in sentinel lymph node--a potential source for diagnostic error.

Authors:  Nadeem Zafar
Journal:  Breast J       Date:  2007 May-Jun       Impact factor: 2.431

3.  Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer--a potential diagnostic pitfall.

Authors:  Ewan K A Millar; Stephanie Inder; Jodi Lynch
Journal:  Histopathology       Date:  2009-04       Impact factor: 5.087

4.  Benign lymph node inclusions mimicking metastatic carcinoma.

Authors:  C J Fisher; S Hill; R R Millis
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

Authors:  Ian C Smith; Steven D Heys; Andrew W Hutcheon; Iain D Miller; Simon Payne; Fiona J Gilbert; Antoinne K Ah-See; Oleg Eremin; Leslie G Walker; Tarun K Sarkar; S Peter Eggleton; Keith N Ogston
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

Review 6.  Granulocyte colony-stimulating factor administration: adverse events.

Authors:  Anita D'Souza; Ishmael Jaiyesimi; Lance Trainor; Padmaja Venuturumili
Journal:  Transfus Med Rev       Date:  2008-10

7.  Extramedullary hematopoiesis during therapy with granulocyte colony-stimulating factor.

Authors:  J Redmond; R S Kantor; H E Auerbach; M D Spiritos; J T Moore
Journal:  Arch Pathol Lab Med       Date:  1994-10       Impact factor: 5.534

  7 in total
  4 in total

Review 1.  Sentinel lymph nodes for breast carcinoma: an update on current practice.

Authors:  Aoife Maguire; Edi Brogi
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

2.  Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia.

Authors:  Joslin M Bowen; Anamarija M Perry; Erin Quist; Mojtaba Akhtari
Journal:  Case Rep Pathol       Date:  2015-04-16

3.  Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review.

Authors:  Youting Bao; Zhichao Liu; Meiying Guo; Butuo Li; Xindong Sun; Linlin Wang
Journal:  Cancer Manag Res       Date:  2018-06-08       Impact factor: 3.989

4.  Generalized lymphadenopathy secondary to isolated extramedullary hematopoiesis as an initial manifestation of primary myelofibrosis.

Authors:  Mansour S Aljabry; Shuaa Asiri; Tayseer Elsafi; Ghaleb Elyamany
Journal:  Hematol Rep       Date:  2018-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.